Furthermore, given their prevalence in APS-1, RAG1/RAG2-associated immunodeficiencies, SLE, and now IPEX, it will be important to consider type I IFN ACAAs as potential diagnostics and biomarkers both in immunodeficiency and autoimmunity. The gene discussed is RAG2; the disease is immune system disorder.